Detalhe da pesquisa
1.
JMJD6 protects against isoproterenol-induced cardiac hypertrophy via inhibition of NF-κB activation by demethylating R149 of the p65 subunit.
Acta Pharmacol Sin
; 44(9): 1777-1789, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37186122
2.
C33(S), a novel PDE9A inhibitor, protects against rat cardiac hypertrophy through upregulating cGMP signaling.
Acta Pharmacol Sin
; 38(9): 1257-1268, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28649129
3.
Synthesis of the novel PARP-1 inhibitor AG-690/11026014 and its protective effects on angiotensin II-induced mouse cardiac remodeling.
Acta Pharmacol Sin
; 38(5): 638-650, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28239158